PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
42.50%
Some net income increase while TRVN is negative at -0.98%. John Neff would see a short-term edge over the struggling competitor.
0.99%
Less D&A growth vs. TRVN's 6.74%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
No Data
No Data available this quarter, please select a different quarter.
-10.02%
Both cut yoy SBC, with TRVN at -5.44%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
66.71%
Well above TRVN's 104.16% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
AP growth well above TRVN's 100.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-209.52%
Both reduce yoy usage, with TRVN at -125.73%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
100.00%
Some yoy increase while TRVN is negative at -120.68%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
51.97%
Operating cash flow growth 1.25-1.5x TRVN's 37.31%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.02%
Negative yoy issuance while TRVN is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.